Chan Young Shin

Title: Innovations by Chan Young Shin

Introduction

Chan Young Shin is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neuropsychiatric disorders. With a total of three patents to his name, his work focuses on innovative methods for addressing complex health issues.

Latest Patents

One of Chan Young Shin's latest patents is a method of treating autism spectrum disorders using piperazine-1-carboxamidine or a pharmaceutically acceptable salt thereof. This invention relates to a pharmaceutical composition aimed at preventing or treating autism spectrum disorder. The piperazine-1-carboxamidine has shown promising effects in valproic acid-induced autism rat models, improving social interaction and reducing hyperactivity and impulsive behaviors. Another significant patent involves a pharmaceutical composition for treating or preventing neuropsychiatric diseases, which contains flavone-6-C-glucose derivatives as active ingredients. This composition is designed to effectively treat cognitive dysfunction disorders such as dementia, amnesia, and anxiety disorders.

Career Highlights

Chan Young Shin has worked with various companies throughout his career, including Dae Hwa Pharma Co., Ltd. and Neuroventi. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Some of his notable coworkers include Jong Hoon Ryu and Jae Hoon Cheong. Their collaborative efforts have further advanced the research and development of effective treatments in the pharmaceutical field.

Conclusion

Chan Young Shin's innovative work in the pharmaceutical industry highlights his commitment to improving the lives of individuals with neuropsychiatric disorders. His patents reflect a deep understanding of complex health issues and a dedication to finding effective solutions.